CLINICAL_TRIALS
trial_result
· 2022-02-14
Clinical Trial Update: Efficacy of Metformin for Sputum Conversion in Patients With Active Pulmonary Tuberculosis [Phase 1, Phase 2]
Summary
A clinical trial update evaluates the efficacy of metformin for sputum conversion in patients with active pulmonary tuberculosis (Phase 1/Phase 2).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mahidol University | Conditions: Tuberculosis, Pulmonary | Phase 1, Phase 2 | Status: UNKNOWN